Menu

AAAS Fellowship Decision Criticized

The chemist charged with felony labor code violations following a 2008 lab fire that killed a research assistant was recently named an American Association for the Advancement of Science fellow.

Dec 11, 2015
Bob Grant

Fellowship rosettes (pictured) are presented to newly elected fellows. AAAS

Biochemist Patrick Harran of the University of California, Los Angeles (UCLA), has been named one of the fellows of the American Association for the Advancement of Science (AAAS) for 2015. Harran joins 346 other fellows from diverse disciplines and from institutions across the nation for their “contributions to innovation, education, and scientific leadership.”

But Harran’s election is being criticized due his role in a tragedy that unfolded in his lab seven years ago. On December 29, 2008, Harran’s research assistant, 23-year-old Sheharbano “Sheri” Sangji, was badly burned in a fire that engulfed her clothes and body as she handled a dangerous chemical, tert-butyllithium. Sangji, who was not wearing the proper protective lab coat as she conducted the experiment, died from her injuries 18 days later. In 2011, Harran was charged with three felony counts of health and safety code violations that contributed to the tragic accident. Avoiding jail time, Harran was forced to pay $10,000 and served 800 hours of community service, in addition to other penalties.

Sangji’s family has written a letter to Gerald Fink, president of AAAS, Phillip Sharp, chairman of the association’s board of directors, and members of the AAAS council, asking that they reconsider their decision to honor Harran. “No family should have to deal with our loss,” Naveen Sangji and M. Hussain Sangji wrote on behalf of the Sangji family. “And certainly, no principal investigator who runs their laboratory in a criminally negligent manner as Patrick Harran has should be bestowed with any awards. We respectfully request that you refuse to honor the unsafe science conducted by an unethical scientist.”

Ginger Pinholster, AAAS director in the office of public programs, told UCLA’s Daily Bruin that the decision to award Harran a fellowship was tied only to his scientific achievements. “(Selection as a fellow) doesn’t reflect behavior or other issues,” Pinholster told the campus newspaper. According to the Daily Bruin, Harran could not be reached for comment.

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
NRGene has launched a new product that aims to empower breeding and maximize agricultural yield as part of the Denovo assembly product suite offered by the company.
Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
Scientists presented more than 30 abstracts featuring Bio-Rad’s Droplet Digital PCR (ddPCR) technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4.